1 Study Coverage 1.1 Gardasil (HPV Vaccine) Product Introduction 1.2 Market by Type 1.2.1 Global Gardasil (HPV Vaccine) Market Size Growth Rate by Type 1.2.2 HPV 2 Valent Vaccine 1.2.3 HPV 4 Valent Vaccine 1.2.4 HPV 9 Valent Vaccine 1.3 Market by Application 1.3.1 Global Gardasil (HPV Vaccine) Market Size Growth Rate by Application 1.3.2 Hpv16 Type 1.3.3 Hpv18 Type 1.3.4 High Risk Virus (Beside Hpv16,Hpv18) 1.3.5 Low Risk Virus 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Gardasil (HPV Vaccine) Market Size, Estimates and Forecasts 2.1.1 Global Gardasil (HPV Vaccine) Revenue 2016-2027 2.1.2 Global Gardasil (HPV Vaccine) Sales 2016-2027 2.2 Global Gardasil (HPV Vaccine), Market Size by Region: 2016 VS 2021 VS 2027 2.3 Gardasil (HPV Vaccine) Historical Market Size by Region (2016-2021) 2.3.1 Global Gardasil (HPV Vaccine) Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Gardasil (HPV Vaccine) Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Gardasil (HPV Vaccine) Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Gardasil (HPV Vaccine) Sales Forecast by Region (2022-2027) 2.4.2 Global Gardasil (HPV Vaccine) Revenue Forecast by Region (2022-2027) 3 Global Gardasil (HPV Vaccine) Competitor Landscape by Players 3.1 Global Top Gardasil (HPV Vaccine) Manufacturers by Sales 3.1.1 Global Gardasil (HPV Vaccine) Sales by Manufacturer (2016-2021) 3.1.2 Global Gardasil (HPV Vaccine) Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Gardasil (HPV Vaccine) Manufacturers by Revenue 3.2.1 Key Gardasil (HPV Vaccine) Manufacturers Covered: Ranking by Revenue 3.2.2 Global Gardasil (HPV Vaccine) Revenue by Manufacturers (2016-2021) 3.2.3 Global Gardasil (HPV Vaccine) Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Gardasil (HPV Vaccine) Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Gardasil (HPV Vaccine) Revenue in 2020 3.2.6 Global Gardasil (HPV Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Gardasil (HPV Vaccine) Price by Manufacturers 3.4 Global Gardasil (HPV Vaccine) Manufacturing Base Distribution, Product Types 3.4.1 Gardasil (HPV Vaccine) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Gardasil (HPV Vaccine) Product Type 3.4.3 Date of International Manufacturers Enter into Gardasil (HPV Vaccine) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Gardasil (HPV Vaccine) Market Size by Type (2016-2021) 4.1.1 Global Gardasil (HPV Vaccine) Sales by Type (2016-2021) 4.1.2 Global Gardasil (HPV Vaccine) Revenue by Type (2016-2021) 4.1.3 Gardasil (HPV Vaccine) Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Gardasil (HPV Vaccine) Market Size Forecast by Type (2022-2027) 4.2.1 Global Gardasil (HPV Vaccine) Sales Forecast by Type (2022-2027) 4.2.2 Global Gardasil (HPV Vaccine) Revenue Forecast by Type (2022-2027) 4.2.3 Gardasil (HPV Vaccine) Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Gardasil (HPV Vaccine) Market Size by Application (2016-2021) 5.1.1 Global Gardasil (HPV Vaccine) Sales by Application (2016-2021) 5.1.2 Global Gardasil (HPV Vaccine) Revenue by Application (2016-2021) 5.1.3 Gardasil (HPV Vaccine) Price by Application (2016-2021) 5.2 Gardasil (HPV Vaccine) Market Size Forecast by Application (2022-2027) 5.2.1 Global Gardasil (HPV Vaccine) Sales Forecast by Application (2022-2027) 5.2.2 Global Gardasil (HPV Vaccine) Revenue Forecast by Application (2022-2027) 5.2.3 Global Gardasil (HPV Vaccine) Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan Gardasil (HPV Vaccine) Market Size YoY Growth 2016-2027 6.1.1 Japan Gardasil (HPV Vaccine) Sales YoY Growth 2016-2027 6.1.2 Japan Gardasil (HPV Vaccine) Revenue YoY Growth 2016-2027 6.1.3 Japan Gardasil (HPV Vaccine) Market Share in Global Market 2016-2027 6.2 Japan Gardasil (HPV Vaccine) Market Size by Players (International and Local Players) 6.2.1 Japan Top Gardasil (HPV Vaccine) Players by Sales (2016-2021) 6.2.2 Japan Top Gardasil (HPV Vaccine) Players by Revenue (2016-2021) 6.3 Japan Gardasil (HPV Vaccine) Historic Market Review by Type (2016-2021) 6.3.1 Japan Gardasil (HPV Vaccine) Sales Market Share by Type (2016-2021) 6.3.2 Japan Gardasil (HPV Vaccine) Revenue Market Share by Type (2016-2021) 6.3.3 Japan Gardasil (HPV Vaccine) Price by Type (2016-2021) 6.4 Japan Gardasil (HPV Vaccine) Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan Gardasil (HPV Vaccine) Sales Forecast by Type (2022-2027) 6.4.2 Japan Gardasil (HPV Vaccine) Revenue Forecast by Type (2022-2027) 6.4.3 Japan Gardasil (HPV Vaccine) Price Forecast by Type (2022-2027) 6.5 Japan Gardasil (HPV Vaccine) Historic Market Review by Application (2016-2021) 6.5.1 Japan Gardasil (HPV Vaccine) Sales Market Share by Application (2016-2021) 6.5.2 Japan Gardasil (HPV Vaccine) Revenue Market Share by Application (2016-2021) 6.5.3 Japan Gardasil (HPV Vaccine) Price by Application (2016-2021) 6.6 Japan Gardasil (HPV Vaccine) Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan Gardasil (HPV Vaccine) Sales Forecast by Application (2022-2027) 6.6.2 Japan Gardasil (HPV Vaccine) Revenue Forecast by Application (2022-2027) 6.6.3 Japan Gardasil (HPV Vaccine) Price Forecast by Application (2022-2027) 7 North America 7.1 North America Gardasil (HPV Vaccine) Market Size YoY Growth 2016-2027 7.2 North America Gardasil (HPV Vaccine) Market Facts & Figures by Country 7.2.1 North America Gardasil (HPV Vaccine) Sales by Country (2016-2021) 7.2.2 North America Gardasil (HPV Vaccine) Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Gardasil (HPV Vaccine) Market Size YoY Growth 2016-2027 8.2 Asia Pacific Gardasil (HPV Vaccine) Market Facts & Figures by Region 8.2.1 Asia Pacific Gardasil (HPV Vaccine) Sales by Region (2016-2021) 8.2.2 Asia Pacific Gardasil (HPV Vaccine) Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Gardasil (HPV Vaccine) Market Size YoY Growth 2016-2027 9.2 Europe Gardasil (HPV Vaccine) Market Facts & Figures by Country 9.2.1 Europe Gardasil (HPV Vaccine) Sales by Country (2016-2021) 9.2.2 Europe Gardasil (HPV Vaccine) Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Gardasil (HPV Vaccine) Market Size YoY Growth 2016-2027 10.2 Latin America Gardasil (HPV Vaccine) Market Facts & Figures by Country 10.2.1 Latin America Gardasil (HPV Vaccine) Sales by Country (2016-2021) 10.2.2 Latin America Gardasil (HPV Vaccine) Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Gardasil (HPV Vaccine) Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Gardasil (HPV Vaccine) Market Facts & Figures by Country 11.2.1 Middle East and Africa Gardasil (HPV Vaccine) Sales by Country (2016-2021) 11.2.2 Middle East and Africa Gardasil (HPV Vaccine) Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 GSK 12.1.1 GSK Corporation Information 12.1.2 GSK Description and Business Overview 12.1.3 GSK Gardasil (HPV Vaccine) Sales, Revenue and Gross Margin (2016-2021) 12.1.4 GSK Gardasil (HPV Vaccine) Products Offered 12.1.5 GSK Recent Development 12.2 MSD 12.2.1 MSD Corporation Information 12.2.2 MSD Description and Business Overview 12.2.3 MSD Gardasil (HPV Vaccine) Sales, Revenue and Gross Margin (2016-2021) 12.2.4 MSD Gardasil (HPV Vaccine) Products Offered 12.2.5 MSD Recent Development 12.3 Walvax Biotechnology 12.3.1 Walvax Biotechnology Corporation Information 12.3.2 Walvax Biotechnology Description and Business Overview 12.3.3 Walvax Biotechnology Gardasil (HPV Vaccine) Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Walvax Biotechnology Gardasil (HPV Vaccine) Products Offered 12.3.5 Walvax Biotechnology Recent Development 12.4 Wantai Biological Pharmacy 12.4.1 Wantai Biological Pharmacy Corporation Information 12.4.2 Wantai Biological Pharmacy Description and Business Overview 12.4.3 Wantai Biological Pharmacy Gardasil (HPV Vaccine) Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Wantai Biological Pharmacy Gardasil (HPV Vaccine) Products Offered 12.4.5 Wantai Biological Pharmacy Recent Development 12.11 GSK 12.11.1 GSK Corporation Information 12.11.2 GSK Description and Business Overview 12.11.3 GSK Gardasil (HPV Vaccine) Sales, Revenue and Gross Margin (2016-2021) 12.11.4 GSK Gardasil (HPV Vaccine) Products Offered 12.11.5 GSK Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Gardasil (HPV Vaccine) Industry Trends 13.2 Gardasil (HPV Vaccine) Market Drivers 13.3 Gardasil (HPV Vaccine) Market Challenges 13.4 Gardasil (HPV Vaccine) Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Gardasil (HPV Vaccine) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Gardasil (HPV Vaccine) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of HPV 2 Valent Vaccine Table 3. Major Manufacturers of HPV 4 Valent Vaccine Table 4. Major Manufacturers of HPV 9 Valent Vaccine Table 5. Global Gardasil (HPV Vaccine) Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Gardasil (HPV Vaccine) Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Gardasil (HPV Vaccine) Sales by Regions (2016-2021) & (K Units) Table 8. Global Gardasil (HPV Vaccine) Sales Market Share by Regions (2016-2021) Table 9. Global Gardasil (HPV Vaccine) Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Gardasil (HPV Vaccine) Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Gardasil (HPV Vaccine) Sales Market Share Forecast by Region (2022-2027) Table 12. Global Gardasil (HPV Vaccine) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Gardasil (HPV Vaccine) Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Gardasil (HPV Vaccine) Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Gardasil (HPV Vaccine) Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Gardasil (HPV Vaccine) Manufacturers by Revenue (US$ Million) in 2020 Table 17. Gardasil (HPV Vaccine) Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Gardasil (HPV Vaccine) Revenue Share by Manufacturers (2016-2021) Table 19. Global Gardasil (HPV Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Gardasil (HPV Vaccine) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gardasil (HPV Vaccine) as of 2020) Table 21. Key Manufacturers Gardasil (HPV Vaccine) Price (2016-2021) (US$/Unit) Table 22. Gardasil (HPV Vaccine) Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Gardasil (HPV Vaccine) Product Type Table 24. Date of International Manufacturers Enter into Gardasil (HPV Vaccine) Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Gardasil (HPV Vaccine) Sales by Type (2016-2021) (K Units) Table 27. Global Gardasil (HPV Vaccine) Sales Share by Type (2016-2021) Table 28. Global Gardasil (HPV Vaccine) Revenue by Type (2016-2021) (US$ Million) Table 29. Global Gardasil (HPV Vaccine) Revenue Share by Type (2016-2021) Table 30. Gardasil (HPV Vaccine) Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Gardasil (HPV Vaccine) Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Gardasil (HPV Vaccine) Sales Market Share Forecast by Type (2022-2027) Table 33. Global Gardasil (HPV Vaccine) Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Gardasil (HPV Vaccine) Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Gardasil (HPV Vaccine) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Gardasil (HPV Vaccine) Sales by Application (2016-2021) (K Units) Table 37. Global Gardasil (HPV Vaccine) Sales Share by Application (2016-2021) Table 38. Global Gardasil (HPV Vaccine) Revenue by Application (2016-2021) (US$ Million) Table 39. Global Gardasil (HPV Vaccine) Revenue Share by Application (2016-2021) Table 40. Gardasil (HPV Vaccine) Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Gardasil (HPV Vaccine) Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Gardasil (HPV Vaccine) Sales Market Share Forecast by Application (2022-2027) Table 43. Global Gardasil (HPV Vaccine) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Gardasil (HPV Vaccine) Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Gardasil (HPV Vaccine) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. Japan Gardasil (HPV Vaccine) Sales (K Units) of Key Companies (2016-2021) Table 47. Japan Gardasil (HPV Vaccine) Sales Share by Company (2016-2021) Table 48. Japan Gardasil (HPV Vaccine) Revenue (US$ Million) by Company (2016-2021) Table 49. Japan Gardasil (HPV Vaccine) Revenue Share by Company (2016-2021) Table 50. Japan Gardasil (HPV Vaccine) Sales (K Units) by Type (2016-2021) Table 51. Japan Gardasil (HPV Vaccine) Sales Share by Type (2016-2021) Table 52. Japan Gardasil (HPV Vaccine) Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. Japan Gardasil (HPV Vaccine) Price (US$/Unit) by Type (2016-2021) Table 54. Japan Gardasil (HPV Vaccine) Sales (K Units) by Type (2022-2027) Table 55. Japan Gardasil (HPV Vaccine) Sales Share by Type (2022-2027) Table 56. Japan Gardasil (HPV Vaccine) Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. Japan Gardasil (HPV Vaccine) Revenue Share by Type (2022-2027) Table 58. Japan Gardasil (HPV Vaccine) Price (US$/Unit) by Type (2022-2027) Table 59. Japan Gardasil (HPV Vaccine) Sales (K Units) by Application (2016-2021) Table 60. Japan Gardasil (HPV Vaccine) Sales Share by Application (2016-2021) Table 61. Japan Gardasil (HPV Vaccine) Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. Japan Gardasil (HPV Vaccine) Price (US$/Unit) by Application (2016-2021) Table 63. Japan Gardasil (HPV Vaccine) Sales (K Units) by Application (2022-2027) Table 64. Japan Gardasil (HPV Vaccine) Sales Share by Application (2022-2027) Table 65. Japan Gardasil (HPV Vaccine) Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. Japan Gardasil (HPV Vaccine) Revenue Share by Application (2022-2027) Table 67. Japan Gardasil (HPV Vaccine) Price (US$/Unit) by Application (2022-2027) Table 68. North America Gardasil (HPV Vaccine) Sales by Country (2016-2021) & (K Units) Table 69. North America Gardasil (HPV Vaccine) Sales Market Share by Country (2016-2021) Table 70. North America Gardasil (HPV Vaccine) Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Gardasil (HPV Vaccine) Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Gardasil (HPV Vaccine) Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Gardasil (HPV Vaccine) Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Gardasil (HPV Vaccine) Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Gardasil (HPV Vaccine) Revenue Market Share by Region (2016-2021) Table 76. Europe Gardasil (HPV Vaccine) Sales by Country (2016-2021) & (K Units) Table 77. Europe Gardasil (HPV Vaccine) Sales Market Share by Country (2016-2021) Table 78. Europe Gardasil (HPV Vaccine) Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Gardasil (HPV Vaccine) Revenue Market Share by Country (2016-2021) Table 80. Latin America Gardasil (HPV Vaccine) Sales by Country (2016-2021) & (K Units) Table 81. Latin America Gardasil (HPV Vaccine) Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Gardasil (HPV Vaccine) Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Gardasil (HPV Vaccine) Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Gardasil (HPV Vaccine) Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Gardasil (HPV Vaccine) Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Gardasil (HPV Vaccine) Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Gardasil (HPV Vaccine) Revenue Market Share by Country (2016-2021) Table 88. GSK Corporation Information Table 89. GSK Description and Business Overview Table 90. GSK Gardasil (HPV Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. GSK Gardasil (HPV Vaccine) Product Table 92. GSK Recent Development Table 93. MSD Corporation Information Table 94. MSD Description and Business Overview Table 95. MSD Gardasil (HPV Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. MSD Product Table 97. MSD Recent Development Table 98. Walvax Biotechnology Corporation Information Table 99. Walvax Biotechnology Description and Business Overview Table 100. Walvax Biotechnology Gardasil (HPV Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Walvax Biotechnology Product Table 102. Walvax Biotechnology Recent Development Table 103. Wantai Biological Pharmacy Corporation Information Table 104. Wantai Biological Pharmacy Description and Business Overview Table 105. Wantai Biological Pharmacy Gardasil (HPV Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Wantai Biological Pharmacy Product Table 107. Wantai Biological Pharmacy Recent Development Table 108. Gardasil (HPV Vaccine) Market Trends Table 109. Gardasil (HPV Vaccine) Market Drivers Table 110. Gardasil (HPV Vaccine) Market Challenges Table 111. Gardasil (HPV Vaccine) Market Restraints Table 112. Gardasil (HPV Vaccine) Customers List Table 113. Gardasil (HPV Vaccine) Distributors List Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Gardasil (HPV Vaccine) Product Picture Figure 2. Global Gardasil (HPV Vaccine) Sales Market Share by Type in 2020 & 2027 Figure 3. HPV 2 Valent Vaccine Product Picture Figure 4. HPV 4 Valent Vaccine Product Picture Figure 5. HPV 9 Valent Vaccine Product Picture Figure 6. Global Gardasil (HPV Vaccine) Sales Market Share by Application in 2020 & 2027 Figure 7. Hpv16 Type Figure 8. Hpv18 Type Figure 9. High Risk Virus (Beside Hpv16,Hpv18) Figure 10. Low Risk Virus Figure 11. Gardasil (HPV Vaccine) Report Years Considered Figure 12. Global Gardasil (HPV Vaccine) Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Gardasil (HPV Vaccine) Market Size 2016-2027 (US$ Million) Figure 14. Global Gardasil (HPV Vaccine) Sales 2016-2027 (K Units) Figure 15. Global Gardasil (HPV Vaccine) Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Gardasil (HPV Vaccine) Sales Market Share by Region (2016-2021) Figure 17. Global Gardasil (HPV Vaccine) Sales Market Share by Region in 2020 Figure 18. Global Gardasil (HPV Vaccine) Revenue Market Share by Region (2016-2021) Figure 19. Global Gardasil (HPV Vaccine) Revenue Market Share by Region in 2020 Figure 20. Global Gardasil (HPV Vaccine) Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Gardasil (HPV Vaccine) Revenue in 2020 Figure 22. Gardasil (HPV Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Gardasil (HPV Vaccine) Sales Market Share by Type (2016-2021) Figure 24. Global Gardasil (HPV Vaccine) Sales Market Share by Type in 2020 Figure 25. Global Gardasil (HPV Vaccine) Revenue Market Share by Type (2016-2021) Figure 26. Global Gardasil (HPV Vaccine) Revenue Market Share by Type in 2020 Figure 27. Global Gardasil (HPV Vaccine) Sales Market Share by Application (2016-2021) Figure 28. Global Gardasil (HPV Vaccine) Sales Market Share by Application in 2020 Figure 29. Global Gardasil (HPV Vaccine) Revenue Market Share by Application (2016-2021) Figure 30. Global Gardasil (HPV Vaccine) Revenue Market Share by Application in 2020 Figure 31. Japan Gardasil (HPV Vaccine) Sales Growth Rate 2016-2027 (K Units) Figure 32. Japan Gardasil (HPV Vaccine) Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. Japan Gardasil (HPV Vaccine) Market Share in Global Market 2016-2027 Figure 34. Japan 5 and 10 Largest Gardasil (HPV Vaccine) Players Market Share by Revenue in Gardasil (HPV Vaccine) in 2020 Figure 35. Japan Gardasil (HPV Vaccine) Revenue Share by Type (2016-2021) Figure 36. Japan Gardasil (HPV Vaccine) Revenue Growth Rate by Type in 2016 & 2020 Figure 37. Japan Gardasil (HPV Vaccine) Revenue Share by Application (2016-2021) Figure 38. Japan Gardasil (HPV Vaccine) Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Gardasil (HPV Vaccine) Sales Growth Rate 2016-2021 (K Units) Figure 40. North America Gardasil (HPV Vaccine) Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Gardasil (HPV Vaccine) Sales Market Share by Country in 2020 Figure 42. North America Gardasil (HPV Vaccine) Revenue Market Share by Country in 2020 Figure 43. U.S. Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 44. U.S. Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 46. Canada Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Gardasil (HPV Vaccine) Sales Growth Rate 2016-2021 (K Units) Figure 48. Europe Gardasil (HPV Vaccine) Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Gardasil (HPV Vaccine) Sales Market Share by Country in 2020 Figure 50. Europe Gardasil (HPV Vaccine) Revenue Market Share by Country in 2020 Figure 51. Germany Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 52. Germany Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 54. France Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 56. U.K. Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 58. Italy Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 60. Russia Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Gardasil (HPV Vaccine) Sales Growth Rate 2016-2021 (K Units) Figure 62. Asia Pacific Gardasil (HPV Vaccine) Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Gardasil (HPV Vaccine) Sales Market Share by Region in 2020 Figure 64. Asia Pacific Gardasil (HPV Vaccine) Revenue Market Share by Region in 2020 Figure 65. China Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 66. China Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 68. Japan Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 70. South Korea Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 72. India Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 74. Australia Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 76. Taiwan Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 78. Indonesia Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 80. Thailand Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 82. Malaysia Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 84. Philippines Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 86. Vietnam Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Gardasil (HPV Vaccine) Sales Growth Rate 2016-2021 (K Units) Figure 88. Latin America Gardasil (HPV Vaccine) Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Gardasil (HPV Vaccine) Sales Market Share by Country in 2020 Figure 90. Latin America Gardasil (HPV Vaccine) Revenue Market Share by Country in 2020 Figure 91. Mexico Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 92. Mexico Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 94. Brazil Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 96. Argentina Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Gardasil (HPV Vaccine) Sales Growth Rate 2016-2021 (K Units) Figure 98. Middle East and Africa Gardasil (HPV Vaccine) Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Gardasil (HPV Vaccine) Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Gardasil (HPV Vaccine) Revenue Market Share by Country in 2020 Figure 101. Turkey Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 102. Turkey Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 104. Saudi Arabia Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. UAE Gardasil (HPV Vaccine) Sales Growth Rate (2016-2021) (K Units) Figure 106. UAE Gardasil (HPV Vaccine) Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Gardasil (HPV Vaccine) Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

GSK MSD Walvax Biotechnology Wantai Biological Pharmacy